Nature Communications

Neoadjuvant serplulimab combined with chemotherapy for resectable oesophageal squamous cell carcinoma: a single-arm, phase 2 trial

2025-12-21

Full text

DOI https://doi.org/10.1038/s41467-025-67589-5